Pharmacogenomics of third-generation aromatase inhibitors

Author： Turkistani Abdullah   Marsh Sharon  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.9, 2012-06, pp. : 1299-1307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aromatase inhibitors

By Grubjesic Simonida   Moriarty Robert M   Pezzuto John M  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. : 1647-1661

Informa Healthcare

Access to resources Recommend Favorite

Third-generation sequencing techniques and applications to drug discovery

By Ozsolak Fatih  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 3, 2012-03 ,pp. : 231-243

Informa Healthcare

Access to resources Recommend Favorite

Increased VTE risk of third-generation OCs not supported

By  

Inpharma, Vol. 1, Iss. 1252, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Economic Considerations in the Prescribing of Third-Generation Antidepressants

By Montgomery Stuart  

PharmacoEconomics, Vol. 23, Iss. 5, 2005-01 ,pp. : 477-491

Adis International

Access to resources Recommend Favorite

Aromatase inhibitors in ovarian stimulation

By Garcia-Velasco Juan A  

Reproductive BioMedicine Online, Vol. 13, Iss. 6, 2006-12 ,pp. : 906-906

Reproductive Healthcare Ltd

Access to resources Recommend Favorite